Advanced search
Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 35, 2022 - Issue 6
Submit an article Journal homepage
738
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Retrospective observational study of asthma and chronic obstructive pulmonary disease prevalence and associated healthcare resource utilization in a large, integrated healthcare system

Ashley W. Collinswortha Baylor Scott & White Health, Dallas, TexasCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8039-7586View further author information
, ScD, MPHORCID Icon,
Andrew L. Masicaa Baylor Scott & White Health, Dallas, Texas;b Texas Health Resources, Arlington, TexasView further author information
, MD, MSCI,
Rustam Kudyakova Baylor Scott & White Health, Dallas, TexasView further author information
, MD, MPH,
Valentina Bayerc Boehringer Ingelheim Pharmaceuticals, Ridgefield, ConnecticutView further author information
, PhD,
Mark W. Millardd Baylor University Medical Center, Dallas, TexasView further author information
, MD &
Asif Shaikhc Boehringer Ingelheim Pharmaceuticals, Ridgefield, ConnecticutView further author information
, MD, MPH
Pages 737-745 | Received 10 Mar 2022, Accepted 27 Jun 2022, Published online: 19 Jul 2022

  • Centers for Disease Control and Prevention. COPD death rates in the United States. https://www.cdc.gov/copd/data.html. Accessed April 16, 2021.
  • Centers for Disease Control and Prevention. Asthma surveillance data. https://www.cdc.gov/asthma/asthmadata.htm. Accessed April 16, 2021.
  • Ford ES, Murphy LB, Khavjou O, Giles WH, Holt JB, Croft JB. Total and state-specific medical and absenteeism costs of COPD among adults aged ≥ 18 years in the United States for 2010 and projections through 2020. Chest. 2015;147(1):31–45. doi:10.1378/chest.14-0972.
  • Nurmagambetov T, Kuwahara R, Garbe P. The economic burden of asthma in the United States, 2008-2013. Ann Am Thorac Soc. 2018;15(3):348–356. doi:10.1513/AnnalsATS.201703-259OC.
  • Wallace AE, Kaila S, Bayer V, et al. Health care resource utilization and exacerbation rates in patients with COPD stratified by disease severity in a commercially insured population. J Manag Care Spec Pharm. 2019;25(2):205–217. doi:10.18553/jmcp.2019.25.2.205.
  • Yaghoubi M, Adibi A, Safari A, FitzGerald JM, Sadatsafavi M. The projected economic and health burden of uncontrolled asthma in the United States. Am J Respir Crit Care Med. 2019;200(9):1102–1112. doi:10.1164/rccm.201901-0016OC.
  • Centers for Disease Control and Prevention. Faststats asthma. https://www.cdc.gov/nchs/fastats/asthma.htm. Accessed April 16, 2020.
  • Centers for Disease Control and Prevention. Faststats COPD. https://www.cdc.gov/nchs/fastats/copd.htm. Accessed April 16, 2020.
  • Murphy SL, Kochanek KD, Xu J, Arias E. Mortality in the United States, 2020. NCHS Data Brief, no 427. Hyattsville, MD: National Center for Health Statistics; 2021. https://www.cdc.gov/nchs/products/databriefs/db427.htm.
  • Zafari Z, Li S, Eakin MN, Bellanger M, Reed RM. Projecting long-term health and economic burden of COPD in the United States. Chest. 2021;159(4):1400–1410. doi:10.1016/j.chest.2020.09.255.
  • Centers for Disease Control and Prevention. COPD costs. https://www.cdc.gov/copd/infographics/copd-costs.html. Accessed April 16, 2020.
  • Lee TM, Tu K, Wing LL, Gershon AS. Identifying individuals with physician-diagnosed chronic obstructive pulmonary disease in primary care electronic medical records: a retrospective chart abstraction study. NPJ Prim Care Respir Med. 2017;27(1):34. doi:10.1038/s41533-017-0035-9.
  • Villa-Roel C, Ospina M, Majumdar SR, et al. Engaging patients and primary care providers in the design of novel opinion leader based interventions for acute asthma in the emergency department: a mixed methods study. BMC Health Serv Res. 2018;18(1):789. doi:10.1186/s12913-018-3587-7.
  • Michas M, Deuchar L, Leigh R, et al; COPD PRIHS-2 Group. Factors influencing the implementation and uptake of a discharge care bundle for patients with acute exacerbation of chronic obstructive pulmonary disease: a qualitative focus group study. Implement Sci Commun. 2020;1:3. doi:10.1186/s43058-020-00017-5.
  • Millard M, Priest E, Cole L, Mularski R, Hazlehurst B, Masica A. Impact of an EMR documentation template as clinical decision support for outpatient asthma management. Chest. 2013;144(4):68A. doi:10.1378/chest.1703596.
  • Global Initiative for Chronic Obstructive Lung Disease. Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2020. https://goldcopd.org/. Accessed April 18, 2020.
  • Global Initiative for Asthma. Global strategy for asthma management and prevention, 2020. https://ginasthma.org/. Accessed April 17, 2020.
  • Liu Y, Pleasants RA, Croft JB, et al. Smoking duration, respiratory symptoms, and COPD in adults aged ≥45 years with a smoking history. COPD. 2015;10:1409–1416. doi:10.2147/COPD.S82259.
  • Lou P, Chen P, Zhang P, et al. Effects of smoking, depression, and anxiety on mortality in COPD patients: a prospective study. Respir Care. 2014;59(1):54–61. doi: 10.4187/respcare.0248.
  • Stead LF, Buitrago D, Preciado N, Sanchez G, Hartmann-Boyce J, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2013;2013(5):CD000165. doi:10.1002/14651858.CD000165.pub4.
  • Price C, Agarwal G, Chan D, et al. Large care gaps in primary care management of asthma: a longitudinal practice audit. BMJ Open. 2019;9(1):e022506. doi:10.1136/bmjopen-2018-022506.
  • Ragaišienė G, Kibarskytė R, Gauronskaitė R, et al. Diagnosing COPD in primary care: what has real life practice got to do with guidelines? Multidiscip Respir Med. 2019;14:28. doi:10.1186/s40248-019-0191-6.
  • Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0218PP.
  • Baldacci S, Simoni M, Maio S, et al; ARGA Collaborative Group. Prescriptive adherence to GINA guidelines and asthma control: an Italian cross sectional study in general practice. Respir Med. 2019;146:10–17. doi:10.1016/j.rmed.2018.11.001.
  • Chinai B, Hunter K, Roy S. Outpatient management of chronic obstructive pulmonary disease: physician adherence to the 2017 Global Initiative for Chronic Obstructive Lung Disease guidelines and its effect on patient outcomes. J Clin Med Res. 2019;11(8):556–562. doi:10.14740/jocmr3888.
  • Ding B, Small M, Holmgren U. A cross-sectional survey of current treatment and symptom burden of patients with COPD consulting for routine care according to GOLD 2014 classifications. Int J Chron Obstruct Pulmon Dis. 2017;12:1527–1537. doi:10.2147/COPD.S133793.
  • Surani S, Aiyer A, Eikermann S, et al. Adoption and adherence to chronic obstructive pulmonary disease GOLD guidelines in a primary care setting. SAGE Open Med. 2019;7:2050312119842221. doi:10.1177/2050312119842221.
  • Weber H, Bassett G, Bartl D, et al. Successful implementation of evidence-based guidelines in a regional emergency department for children presenting with acute asthma. Aust J Rural Health. 2019;27(6):557–562. doi:10.1111/ajr.12544.
  • Watson L, Kerstjens HA, Rabe KF, Kiri V, Visick GT, Postma DS. Obtaining optimal control in mild asthma: theory and practice. Fam Pract. 2005;22(3):305–310. doi:10.1093/fampra/cmi013.
  • Ducharme FM, Ni Chroinin M, Greenstone I, Lasserson TJ. Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children. Cochrane Database Syst Rev. 2010;5:CD005535. doi:10.1002/14651858.CD005535.pub2.
  • Papi A, Corradi M, Pigeon-Francisco C, et al. Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial. Lancet Respir Med. 2013;1(1):23–31. doi:10.1016/S2213-2600(13)70012-2.
  • Patel M, Pilcher J, Pritchard A, et al; SMART Study Group. Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial. Lancet Respir Med. 2013;1(1):32–42. doi:10.1016/S2213-2600(13)70007-9.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.